Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2082 of 6351
-
Massive study seeks to unlock secrets of sudden cardiac arrest
Knowledge-focused OngoingIdentification of Causes and Risk Factors for Out-of-Hospital Cardiac Arrest through Development of Prediction Model and Novel Biomarkers Study Objectives: 1. To identify causes and risk factors of OHCA incidence that are associated with chronic diseases and health behaviors 2.…
Sponsor: Seoul National University Hospital • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC
-
HIV pill breakthrough: 4-Day week works as well as daily dosing
Disease control CompletedThe trial is an open-label, multicenter, prospective, randomized trial in 2 parallel groups, evaluating at W48, the non-inferiority of antiretroviral treatment taken 4 consecutive days a week versus continuous therapy, in HIV infected patients with controlled viral load for at le…
Phase 3 • Sponsor: ANRS, Emerging Infectious Diseases • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Experimental combo aims to outsmart relapsed blood cancers
Disease control OngoingThis phase I trial studies the side effects and best dose of ipilimumab when given together with decitabine in treating patients with myelodysplastic syndrome or acute myeloid leukemia that has returned after a period of improvement (relapsed) or does not respond to treatment (re…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 09, 2026 23:00 UTC
-
New hope for kids with relapsed neuroblastoma: targeted drug lorlatinib enters first pediatric trial
Disease control CompletedLorlatinib is a novel inhibitor across ALK variants, including those resistant to crizotinib. In this first pediatric phase 1 trial of lorlatinib, the drug will be utilized as a single agent and in combination with chemotherapy in patients with relapsed/refractory neuroblastoma. …
Phase 1 • Sponsor: New Approaches to Neuroblastoma Therapy Consortium • Aim: Disease control
Last updated Jun 26, 2026 17:00 UTC
-
New hope for rare, aggressive cancer: drug cocktail shows promise in trial
Disease control CompletedPoorly differentiated neuroendocrine carcinomas (NEC) are a sub-group of aggressive neuroendocrine neoplasms (NEN). The most common primary sites are broncho-pulmonary and digestive. The gastroentero-pancreatic NECs (GEP-NEC) represent 7-21% of all of the NENs. Recent data on th…
Phase 2 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 26, 2026 13:11 UTC
-
Can a smart drinking program curb binge drinking and drunk driving?
Prevention Recruiting nowThis study will evaluate effects of a multi-component, population-level intervention on alcohol use and related harms in six intervention cities relative to six matched comparison cities. Intervention components include screening and brief interventions by health providers, other…
Sponsor: HBSA • Aim: Prevention
Last updated Jun 26, 2026 13:09 UTC
-
New needle combo zaps returning liver tumors after failed chemo
Disease control CompletedThis single-center, prospective study evaluates the therapeutic outcomes of saline-augmented bipolar radiofrequency ablation (RFA) with twin internally cooled-perfusion (TICP) electrodes for treating recurrent hepatocellular carcinoma (HCC) following trans-arterial chemoembolizat…
Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Knee cartilage repair: your own cells could be the key
Disease control Recruiting nowThis study was aimed to evaluate effectiveness and safety of autologous chondrocyte suspension for treatment of knee articular cartilage defects.
Sponsor: Centre Hospitalier Universitaire Vaudois • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Video games could replace eye patches for lazy eye
Disease control Recruiting nowTo evaluate the effectiveness of enhanced binocular amblyopia treatments in achieving a more complete and stable recovery.
Sponsor: Retina Foundation of the Southwest • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Sleep or awake? study tests best anesthesia for stroke treatment
Knowledge-focused CompletedObjective of the study: to assess whether pharmacological sedation or general anesthesia for treatment of anterior circulation ischemic stroke with endovascular mechanical thrombectomy is associated with difference in morbidity (neurological outcome and peri-procedural complicati…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Could a cell infusion free liver transplant patients from lifelong drugs?
Disease control CompletedPhase I/II, single center, prospective, open-label, non-controlled, non-randomized, interventional, cohort study in which low risk living donor liver transplant (LDLT) recipients will receive a single infusion of donor-derived DCreg 1 week prior to transplantation. All patients w…
Phase 1/2 • Sponsor: Angus W. Thomson PhD DSc • Aim: Disease control
Last updated Jun 26, 2026 18:28 UTC
-
New drug targets genetic weakness in bladder cancer
Disease control OngoingThis pilot phase II trial studies how well sapanisertib works in treating patients with bladder cancer that has spread from where it started to nearby tissue or lymph nodes (locally advanced) or other places in the body (metastatic) with tuberous sclerosis (TSC)1 and/or TSC2 muta…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New hope for lupus skin flares? drug shows promise in early trial
Disease control CompletedThis 76-week, 3-part Phase 1b/2 study is intended to evaluate the pharmacological properties (pharmacokinetics and pharmacodynamics), safety, tolerability and preliminary effectiveness of TOFA administrated to young adults (18-45 years) with moderately to severely active SLE-CL. …
Phase 1/2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New study tracks quality of life after chest wall surgery for breast cancer
Symptom relief Recruiting nowAlthough chest wall recurrence of breast cancer is uncommon, it represents a difficult clinical scenario. The role of full thickness chest wall resection (FTCWR) for breast cancer recurrence in the chest wall is controversial and is complicated by the fact that no prospective evi…
Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
Experimental HIV vaccine passes early safety test in healthy volunteers
Vaccine CompletedThe purpose of this study is to evaluate the safety, tolerability, and immunogenicity of EnvSeq-1 and CH505 M5 gp120 Envs adjuvanted with GLA-SE in healthy, HIV-uninfected adults.
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Vaccine
Last updated Jun 27, 2026 12:29 UTC
-
New combo attack on lymphoma shows promise in early trial
Disease control CompletedThis phase I/II trial studies the best dose and side effects of dendritic cell therapy, cryosurgery and pembrolizumab in treating patients with non-Hodgkin lymphoma. Vaccines, such as dendritic cell therapy made from a person's tumor cells and white blood cells may help the body …
Phase 1/2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could a common psychiatric drug ease chemo vomiting in kids?
Symptom relief CompletedChemotherapy-induced nausea and vomiting (CINV) are among the most bothersome symptoms during cancer treatment according to children and their parents. Most children receiving highly emetogenic chemotherapy (HEC), including those receiving hematopoietic stem cell transplant (HSCT…
Phase 2 • Sponsor: The Hospital for Sick Children • Aim: Symptom relief
Last updated Aug 29, 2026 00:00 UTC
-
New DNA test aims to predict bloodstream infections in kids with cancer
Knowledge-focused OngoingThe majority of children and adolescents diagnosed with cancer will experience one or more episodes of fever or infection during their course of therapy. The most common microbiologically documented infection is bloodstream infection (BSI), which can be associated with severe sep…
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Jul 22, 2026 00:00 UTC
-
New radiation method HYDRA tested for laryngeal cancer
Disease control Recruiting nowTo find the highest tolerable dose of stereotactic hypofractionated radioablation (HYDRA) radiation that can be given to patients with laryngeal cancer. The safety of this radiation will also be studied.
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Drug combo shows promise in slowing rare sarcomas
Disease control OngoingThis is a two center, 2 arm, Phase II study evaluating the combination of Ribociclib and Everolimus in patients with advanced DDL and LMS who have had at least 1 prior systemic therapy. Patients will be enrolled by sarcoma histology into DDL (Arm A) and LMS (Arm B). The purpose o…
Phase 2 • Sponsor: Fox Chase Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC